The 10,000 Families Cohort: a new study to understand the environmental causes of cancer
万个家庭队列:一项了解癌症环境原因的新研究
基本信息
- 批准号:10335395
- 负责人:
- 金额:$ 107.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-24 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAdvocacyAgeAgricultureAirAncillary StudyAutomobile DrivingBiological MarkersBloodCancer CenterCancer EtiologyCarcinogensCellsChemicalsChildCohort StudiesCollectionCommunitiesCommunity OutreachCountyDataDevelopmentDysmyelopoietic SyndromesEducation and OutreachEnvironmental ExposureEpigenetic ProcessExposure toFamilyFamily StudyFingersFundingGoldHairHematologic AgentsHematologic NeoplasmsHematologyHematopoiesisHemeHeritabilityHigh PrevalenceHispanicsHouseholdHumanImmigrantImmuneImmunityImmunologic MarkersIncidenceIndividualInternational Agency for Research on CancerIowaLinkLongterm Follow-upMalignant NeoplasmsMeasuresMethodologyMethodsMinnesotaNon-Hodgkin&aposs LymphomaOutcomeParticipantPatient RecruitmentsPesticidesPhasePoly-fluoroalkyl substancesPopulationPrevalenceProspective cohortRadonRecording of previous eventsReportingResearchResearch InstituteRiskRisk FactorsRoleRoundupRuralRural PopulationSerumSiliconSiliconesSystemTechnologyTestingTimeUnderrepresented PopulationsUniversitiesUrineVenousWaterWisconsinbasebiobankcancer riskcancer typecarcinogenicitycohortcommunity engagementde novo mutationearly detection biomarkersempowermentepigenomicsethnic minority populationgeographic differenceglyphosatehigh riskinnovationinterestleukemialeukemia/lymphomamicrobiomeneoplasm registryracial and ethnicrecruitresidencerural areastudy populationurban areavirtual
项目摘要
Abstract
The 10,000 Families Study (10KFS) will be a new, family-based cohort study in Minnesota, the ‘Land of 10,000
Lakes’. Due to our high incidence rates of hematologic malignancy (leukemia, lymphoma, and myelodysplastic
syndromes), we will focus our proposal on environmental exposures of concern that are possible hematologic
carcinogens with limited evidence in humans as defined by the International Agency for Research on Cancer
(IARC). This includes glyphosate, poly- and perfluoroalkyl substances (PFAS), and radon, all of which have
well-described geographic variation in prevalence in the state of Minnesota. During the UG3 phase, we will
evaluate innovative exposure assessment methodologies and recruit diverse participants into the 10KFS
cohort. Exposure assessment will include residential history, ambient measures in air and water at current
residence, as well as individual-level exposure assessed with silicone wearable bracelets, serum, hair, and
urine. Participants will be recruited from targeted counties that maximize the exposure distribution to our three
carcinogens of interest and include under-represented populations from rural and immigrant communities. We
will measure clonal hematopoiesis of indeterminate potential (CHIP), a precursor to heme malignancy, and
perturbations in immunity and epigenetics as our primary cancer-related outcomes in the UH3 phase. Our
target is to recruit 8,750 participants from 4,000 households to participate using recruitment strategies that
have been developed and pilot tested. Our central hypothesis is that PFAS, glyphosate and radon contribute to
increased hematologic malignancy specifically, and cancer incidence broadly, in Minnesota. Cancer incidence
will be determined via annual record linkage with the Minnesota Cancer Reporting System (MCRS) and the
Virtual Pooled Registry Cancer Linkage System. The scientific aims in the UG3 phase will be to: 1) evaluate
innovative exposure assessment methods for PFAS and glyphosate that can be easily implemented in a large
scale study and 2) describe the exposure burden in under-represented immigrant populations. We will
complete recruitment of the study population in the UH3 phase where the specific aims are to: 1) determine
whether levels of radon, glyphosate, and PFAS are associated with increased prevalence of CHIP and 2)
utilize epigenomics to test the hypotheses that radon, glyphosate and PFAS exposure are associated with
immune dysregulation and epigenetic signatures. Our community engagement will be conducted in partnership
with the non-profit research institute Hispanic Advocacy and Community Empowerment Through Research
(HACER), the Minnesota Freemasons and Order of the Eastern Star and community educators from the
Extension Center for Family Development. The results of this study will provide needed data to inform whether
these agents are hematologic carcinogens, it will address documented disparities in exposure that occur within
our state and provide a mechanism for community outreach and education concerning these exposures and
any potential cancer link.
抽象的
10,000 个家庭研究 (10KFS) 将是一项新的、以家庭为基础的队列研究,在明尼苏达州这个“10,000 人的土地”
由于我们的血液系统恶性肿瘤(白血病、淋巴瘤和骨髓增生异常)的发病率很高。
综合征),我们将把我们的提案重点放在可能引起血液学问题的环境暴露上
国际癌症研究机构定义的人类致癌物的证据有限
(IARC),其中包括草甘膦、多氟烷基物质和全氟烷基物质 (PFAS) 以及氡,所有这些物质都具有
在 UG3 阶段,我们将详细描述明尼苏达州患病率的地理差异。
评估创新的暴露评估方法并招募不同的参与者加入 10KFS
暴露评估将包括居住史、当前空气和水中的环境措施。
居住地以及使用硅胶可穿戴手环、血清、头发和
参与者将从目标县招募,以最大限度地提高我们三个人的尿液暴露分布。
我们关注的致癌物包括来自农村和移民社区的代表性不足的人群。
将测量不确定潜力的克隆造血(CHIP),这是血红素恶性肿瘤的前兆,并且
免疫和表观遗传学的扰动是 UH3 阶段与癌症相关的主要结果。
目标是招募来自 4,000 个家庭的 8,750 名参与者,使用以下招募策略:
我们的中心假设是 PFAS、草甘膦和氡有助于
明尼苏达州的癌症发病率尤其增加,癌症发病率也明显增加。
将通过与明尼苏达州癌症报告系统 (MCRS) 和
虚拟汇总登记癌症关联系统 UG3 阶段的科学目标是: 1) 评估
PFAS 和草甘膦的创新暴露评估方法,可轻松在大范围内实施
规模研究和 2) 描述代表性不足的移民人群的暴露负担。
在 UH3 阶段完成研究人群的招募,其具体目标是: 1) 确定
氡气、草甘膦和 PFAS 的水平是否与 CHIP 患病率增加有关;2)
利用表观基因组学来检验氡气、草甘膦和 PFAS 暴露与相关的假设
我们的社区参与将合作进行。
与非营利性研究机构“西班牙裔倡导和社区赋权研究”合作
(HACER)、明尼苏达共济会和东方之星勋章以及来自
家庭发展推广中心。这项研究的结果将为是否提供信息提供所需的数据。
这些物质是血液致癌物,它将解决记录在案的暴露差异
我们的州并提供有关这些暴露的社区外展和教育机制
任何潜在的癌症联系。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HEATHER Hammond NELSON其他文献
HEATHER Hammond NELSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HEATHER Hammond NELSON', 18)}}的其他基金
The 10,000 Families Cohort: a new study to understand the environmental causes of cancer
万个家庭队列:一项了解癌症环境原因的新研究
- 批准号:
10494289 - 财政年份:2021
- 资助金额:
$ 107.07万 - 项目类别:
The 10,000 Families Cohort: a new study to understand the environmental causes of cancer
万个家庭队列:一项了解癌症环境原因的新研究
- 批准号:
10900881 - 财政年份:2021
- 资助金额:
$ 107.07万 - 项目类别:
Congenital cytomegalovirus infection, KIR genotypes, and acute lymphoblastic leukemia
先天性巨细胞病毒感染、KIR 基因型和急性淋巴细胞白血病
- 批准号:
9897463 - 财政年份:2018
- 资助金额:
$ 107.07万 - 项目类别:
MOLECULAR EPIDEMIOLOGY OF NON-MELANOMA SKIN CANCER
非黑色素瘤皮肤癌的分子流行病学
- 批准号:
2884583 - 财政年份:1999
- 资助金额:
$ 107.07万 - 项目类别:
Molecular Epidemiology of Non-Melanoma Skin Cancer
非黑色素瘤皮肤癌的分子流行病学
- 批准号:
6915777 - 财政年份:1999
- 资助金额:
$ 107.07万 - 项目类别:
Molecular Epidemiology of Non-Melanoma Skin Cancer
非黑色素瘤皮肤癌的分子流行病学
- 批准号:
6786055 - 财政年份:1999
- 资助金额:
$ 107.07万 - 项目类别:
Molecular Epidemiology of Non-Melanoma Skin Cancer
非黑色素瘤皮肤癌的分子流行病学
- 批准号:
8071174 - 财政年份:1999
- 资助金额:
$ 107.07万 - 项目类别:
Molecular Epidemiology of Non-Melanoma Skin Cancer
非黑色素瘤皮肤癌的分子流行病学
- 批准号:
7851050 - 财政年份:1999
- 资助金额:
$ 107.07万 - 项目类别:
相似国自然基金
单核细胞产生S100A8/A9放大中性粒细胞炎症反应调控成人Still病发病及病情演变的机制研究
- 批准号:82373465
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SERPINF1/SRSF6/B7-H3信号通路在成人B-ALL免疫逃逸中的作用及机制研究
- 批准号:82300208
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于动态信息的深度学习辅助设计成人脊柱畸形手术方案的研究
- 批准号:82372499
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
The RaDIANT Health Systems Intervention for Equity in Kidney Transplantation
Radiant 卫生系统干预肾移植的公平性
- 批准号:
10681998 - 财政年份:2023
- 资助金额:
$ 107.07万 - 项目类别:
The Promoting Resilience in Stress Management (PRISM) Intervention: a multi-site randomized controlled trial for Adolescents and Young Adults with advanced cancer
促进压力管理复原力 (PRISM) 干预:一项针对患有晚期癌症的青少年和年轻人的多中心随机对照试验
- 批准号:
10895146 - 财政年份:2023
- 资助金额:
$ 107.07万 - 项目类别:
Building Social and Structural Connections for the Prevention of OUD among Youth Experiencing Homelessness: An RCT Examining Biopsychosocial Mechanisms
建立社会和结构联系以预防无家可归青年中的 OUD:一项检验生物心理社会机制的随机对照试验
- 批准号:
10775030 - 财政年份:2023
- 资助金额:
$ 107.07万 - 项目类别: